Free Trial

Myriad Genetics (MYGN) News Today

Myriad Genetics logo
$4.15 +0.24 (+6.14%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$4.16 +0.00 (+0.12%)
As of 05/27/2025 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MYGN Latest News

Myriad Genetics, Inc. stock logo
Scotiabank Downgrades Myriad Genetics (NASDAQ:MYGN) to Sector Perform
Scotiabank downgraded shares of Myriad Genetics from a "sector outperform" rating to a "sector perform" rating and set a $6.00 target price on the stock. in a research report on Wednesday.
Myriad Genetics, Inc. stock logo
Myriad Genetics, Inc. (NASDAQ:MYGN) Receives Consensus Recommendation of "Hold" from Brokerages
Myriad Genetics, Inc. (NASDAQ:MYGN - Get Free Report) has received a consensus rating of "Hold" from the seventeen ratings firms that are presently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and five have a
Myriad Genetics, Inc. stock logo
Point72 Asset Management L.P. Sells 715,107 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Point72 Asset Management L.P. lowered its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 67.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 348,604 shares of the company's stock after selling
Myriad Genetics, Inc. stock logo
Bank of America Corp DE Sells 495,911 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Bank of America Corp DE lowered its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 17.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,402,708 shares of the company's stock after selling 495,91
Myriad Genetics, Inc. stock logo
Northern Trust Corp Buys 64,923 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
Northern Trust Corp increased its stake in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 6.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,032,132 shares of the company's stock after purchasing an additional 64,923 shares during the p
Myriad Genetics, Inc. stock logo
83,382 Shares in Myriad Genetics, Inc. (NASDAQ:MYGN) Acquired by Balyasny Asset Management L.P.
Balyasny Asset Management L.P. acquired a new position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 83,382 shares of the company's stock, valued at approximately $1,
Myriad Genetics, Inc. stock logo
D. E. Shaw & Co. Inc. Purchases 668,429 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
D. E. Shaw & Co. Inc. lifted its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 58.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,819,814 shares of the company's stock after a
Myriad Genetics, Inc. stock logo
Wolfe Research Downgrades Myriad Genetics (NASDAQ:MYGN) to Peer Perform
Wolfe Research cut Myriad Genetics from an "outperform" rating to a "peer perform" rating in a research note on Thursday.
Myriad Genetics, Inc. stock logo
Myriad Genetics (NASDAQ:MYGN) Downgraded to Equal Weight Rating by Wells Fargo & Company
Wells Fargo & Company cut Myriad Genetics from an "overweight" rating to an "equal weight" rating and set a $6.00 price objective for the company. in a research report on Wednesday.
Myriad Genetics, Inc. stock logo
Myriad Genetics, Inc. (NASDAQ:MYGN) Stock Position Reduced by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP trimmed its position in Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 6.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,272,355 shares of the company's stock after selling 151,122 sha
Myriad Genetics, Inc. stock logo
First Trust Advisors LP Sells 46,831 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)
First Trust Advisors LP trimmed its position in shares of Myriad Genetics, Inc. (NASDAQ:MYGN - Free Report) by 25.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 139,545 shares of the company's stock after selling 4
Myriad Genetics's Earnings: A Preview
Myriad Genetics, Inc. stock logo
Myriad Genetics (MYGN) Projected to Post Earnings on Tuesday
Myriad Genetics (NASDAQ:MYGN) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-6-myriad-genetics-inc-stock/)
Myriad Genetics, Inc. stock logo
Myriad Genetics (NASDAQ:MYGN) Reaches New 1-Year Low - What's Next?
Myriad Genetics (NASDAQ:MYGN) Hits New 1-Year Low - What's Next?
Get Myriad Genetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter.

MYGN Media Mentions By Week

MYGN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MYGN
News Sentiment

0.11

1.03

Average
Medical
News Sentiment

MYGN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MYGN Articles
This Week

13

8

MYGN Articles
Average Week

Get Myriad Genetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MYGN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:MYGN) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners